查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1788305

全球肺支架市場

Pulmonary Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球肺支架市場規模將達到 3.311 億美元

全球肺支架市場規模預計在2024年達到2.488億美元，預計2024年至2030年期間的複合年成長率為4.9%，到2030年將達到3.311億美元。自動擴張型支架是本報告分析的細分市場之一，預計其複合年成長率為5.8%，到分析期結束時規模將達到2.215億美元。球囊擴張型支架細分市場在分析期間的複合年成長率預計為3.2%。

美國市場規模估計為 6,540 萬美元，中國市場預計複合年成長率為 4.7%

美國肺支架市場規模預計在2024年達到6,540萬美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到5,320萬美元，在2024-2030年的分析期間內，複合年成長率為4.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為4.6%和4.2%。在歐洲，預計德國的複合年成長率為3.9%。

全球肺支架市場－主要趨勢與促進因素摘要

為什麼肺支架在呼吸醫學中變得不可或缺？

肺支架在治療氣管支氣管狹窄、肺癌、慢性阻塞性肺病(COPD) 和術後併發症等引起的氣道阻塞方面發揮關鍵作用。這些支架有助於保持呼吸道通暢性，使患者呼吸更順暢，提高他們的整體生活品質。隨著環境污染、吸菸和人口老化導致呼吸系統疾病的盛行率持續上升，對肺支架的需求正在顯著成長。與侵入性外科手術不同，支氣管鏡支架置入術提供了一種微創解決方案，可縮短患者復原時間和住院時間。呼吸護理中對非手術治療方法的日益成長的偏好推動了肺支架技術的進步，從而導致了更有效、更耐用和生物相容性的支架的開發。醫療保健提供者擴大將肺支架納入治療複雜氣道疾病的治療通訊協定中，全球醫院和專科診所擴大採用肺支架。

技術進步如何提升肺支架的性能？

肺支架設計和材料的最新創新已顯著提高其臨床療效和患者預後。傳統的金屬和矽膠支架已得到改進，可最大限度地降低移位風險並提高氣道內的長期穩定性。自動擴張型支架的引入，可貼合氣道輪廓，減少頻繁重新定位的需要，提高了手術成功率。此外，已開發出塗有抗發炎和抗增殖劑的藥物釋放型支架，以防止血管再阻塞並降低重複干預的可能性。生物可吸收支架會隨著時間的推移逐漸溶解，已成為臨時氣道支持的一種有前途的選擇，無需進行支架移除手術。此外，高解析度電腦斷層掃描和引導支氣管鏡檢查等影像技術的改進，提高了支架放置的準確性，減少了併發症並最佳化了治療結果。隨著正在進行的研究集中在提高支架的靈活性、生物相容性和長期療效，下一代肺支架有望為呼吸醫學樹立新的標準。

哪些因素推動了肺支架的採用？

肺部疾病的日益普及和人們對微創治療方案認知的不斷提高，推動了對肺支架的需求。與傳統的開放性手術相比，患者和醫療保健提供者更青睞支氣管鏡支架置入術，因為其風險更低、恢復更快、患者舒適度更高。肺癌發生率的上升，尤其是在老齡化社會中，進一步加速了對呼吸道管理解決方案的需求，肺支架廣泛用於晚期癌症患者的姑息治療。此外，由於空氣污染和吸菸習慣，全球慢性阻塞性肺病 (COPD) 患者數量不斷增加，導致需要植入支架以有效管理氣道阻塞的情況增加。支架製造技術的進步，例如結合金屬和矽膠優點的混合設計，由於其耐用性和功能性的提高，也促進了市場成長。許多已開發國家對肺部干預的報銷政策進一步鼓勵醫院和專科診所採用這些設備進行呼吸道管理。

推動肺支架市場成長的關鍵因素有哪些？

全球肺支架市場的成長受到多種關鍵因素的推動，包括慢性呼吸系統疾病盛行率的上升、支架設計和材料的進步，以及微創呼吸道管理技術的日益普及。醫療保健基礎設施的擴張，尤其是在新興市場，正在改善先進呼吸治療的可及性，並推動對肺支架的需求。人工智慧影像處理和機器人支氣管鏡的整合也提高了手術的準確性，使支架置入更加有效，並降低了併發症率。此外，醫療機構、研究機構和醫療設備製造商對呼吸照護的投入不斷增加，正在加速肺支架技術的創新。下一代支架的監管核准，以及醫療設備製造商和醫療機構之間日益增多的合作，正在進一步推動市場擴張。隨著對有效呼吸道管理解決方案的需求持續成長，肺支架市場有望持續擴張，其持續的進步將塑造呼吸護理的未來。

部分

產品（自動擴張型支架、球囊擴張型支架）、材質（金屬、矽膠、混合）、型式（氣管支氣管支架、喉頭支架）

受訪公司範例

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.（Cordis）
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • MI Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech（Nanjing）Co., Ltd.

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP32727

Global Pulmonary Stents Market to Reach US$331.1 Million by 2030

The global market for Pulmonary Stents estimated at US$248.8 Million in the year 2024, is expected to reach US$331.1 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Self-expandable Stents, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$221.5 Million by the end of the analysis period. Growth in the Balloon-expandable Stents segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.4 Million While China is Forecast to Grow at 4.7% CAGR

The Pulmonary Stents market in the U.S. is estimated at US$65.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$53.2 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Pulmonary Stents Market - Key Trends & Drivers Summarized

Why Are Pulmonary Stents Becoming Essential in Respiratory Medicine?

Pulmonary stents play a crucial role in managing airway obstruction caused by conditions such as tracheobronchial stenosis, lung cancer, chronic obstructive pulmonary disease (COPD), and post-surgical complications. These stents help maintain airway patency, allowing patients to breathe more easily and improving overall quality of life. As the prevalence of respiratory disorders continues to rise due to environmental pollution, smoking, and aging populations, the demand for pulmonary stents has grown significantly. Unlike invasive surgical procedures, stent placement via bronchoscopy offers a minimally invasive solution, reducing patient recovery time and hospital stays. The increasing preference for non-surgical interventions in respiratory care has driven advancements in pulmonary stent technology, making them more effective, durable, and biocompatible. Healthcare providers are increasingly incorporating pulmonary stents into treatment protocols to manage complex airway diseases, leading to expanded adoption across hospitals and specialty clinics worldwide.

How Are Technological Advancements Improving Pulmonary Stent Performance?

Recent innovations in pulmonary stent design and materials have significantly enhanced their clinical efficacy and patient outcomes. Traditional metal and silicone stents have been refined to minimize migration risks and improve long-term stability within the airways. The introduction of self-expanding stents, which adapt to airway contours and reduce the need for frequent repositioning, has improved procedural success rates. Furthermore, drug-eluting pulmonary stents, coated with anti-inflammatory or anti-proliferative agents, are being developed to prevent restenosis and reduce the likelihood of repeat interventions. Bioresorbable stents, which gradually dissolve over time, are emerging as a promising alternative for temporary airway support, eliminating the need for stent removal procedures. Enhanced imaging technologies such as high-resolution CT scans and guided bronchoscopy have also improved the precision of stent placement, reducing complications and optimizing treatment outcomes. As research continues to focus on improving stent flexibility, biocompatibility, and long-term efficacy, the next generation of pulmonary stents is expected to set new standards in respiratory medicine.

What Factors Are Driving the Adoption of Pulmonary Stents?

The increasing prevalence of lung diseases, coupled with rising awareness about minimally invasive treatment options, has fueled the demand for pulmonary stents. Patients and healthcare providers are favoring bronchoscopic stenting over traditional open surgeries due to lower risks, faster recovery times, and improved patient comfort. The rising incidence of lung cancer, particularly in aging populations, has further accelerated the need for airway management solutions, with pulmonary stents being widely used for palliative care in advanced-stage cancer patients. Additionally, the growing number of COPD cases worldwide, driven by air pollution and smoking habits, has led to increased stent placements to manage airway obstruction effectively. Technological advancements in stent manufacturing, such as hybrid designs that combine the benefits of metal and silicone, are also contributing to market growth by offering enhanced durability and functionality. The availability of reimbursement policies for pulmonary interventions in many developed countries is further encouraging hospitals and specialty clinics to adopt these devices for airway management.

What Are the Key Drivers Fueling Growth in the Pulmonary Stents Market?

The growth in the global pulmonary stents market is driven by several key factors, including the rising incidence of chronic respiratory diseases, advancements in stent design and materials, and the increasing adoption of minimally invasive airway management techniques. The expansion of healthcare infrastructure, particularly in emerging markets, is improving access to advanced respiratory treatments, boosting demand for pulmonary stents. The integration of AI-powered imaging and robotic-assisted bronchoscopy is also enhancing procedural accuracy, making stent placement more effective and reducing complication rates. Furthermore, the growing investment in respiratory care by healthcare providers, research institutions, and medical device manufacturers is accelerating innovation in pulmonary stent technology. Regulatory approvals for next-generation stents, along with increasing collaborations between medical device companies and healthcare organizations, are further driving market expansion. As the demand for effective airway management solutions continues to grow, the pulmonary stents market is poised for sustained development, with ongoing advancements shaping the future of respiratory care.

SCOPE OF STUDY:

The report analyzes the Pulmonary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Self-expandable Stents, Balloon-expandable Stents); Material (Metal, Silicon, Hybrid); Type (Tracheobronchial Stents, Laryngeal Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc. (Cordis)
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • M.I. Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech (Nanjing) Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pulmonary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Tracheobronchial Obstructions and Airway Stenosis Throws the Spotlight on Pulmonary Stent Utilization
    • Expansion of Interventional Pulmonology and Minimally Invasive Airway Management Drives Adoption of Pulmonary Stents
    • Increasing Prevalence of COPD, Lung Cancer, and Post-Intubation Stenosis Strengthens Business Case for Airway Stenting
    • Advancements in Stent Design, Flexibility, and Radial Force Propel Innovation in Customized Pulmonary Stents
    • Surge in Geriatric Population and Age-Related Respiratory Disorders Drives Demand for Long-Term Airway Patency Solutions
    • Development of Drug-Eluting and Bioabsorbable Pulmonary Stents Expands the Therapeutic Scope for Chronic Pulmonary Conditions
    • Rising Adoption of 3D Printing and Patient-Specific Stent Models Enhances Procedural Precision and Clinical Outcomes
    • Integration of Bronchoscopic Navigation and Imaging Systems Improves Placement Accuracy and Procedural Safety
    • Growing Use of Temporary and Removable Silicone Stents Spurs Preference for Less Invasive and Reversible Airway Interventions
    • Regulatory Approvals and Reimbursement Policies Supporting Interventional Pulmonary Devices Propel Market Penetration
    • Increased Focus on Airway Rescue and Palliative Interventions in Advanced-Stage Oncology Boosts Pulmonary Stent Procedures
    • Emergence of Customized Hybrid Stents Combining Metal and Polymer Components Enhances Functional Performance
    • Collaborations Between Pulmonologists and Thoracic Surgeons Drive Adoption of Multidisciplinary Airway Management Approaches
    • Expansion of Specialized Centers for Complex Airway Disorders Spurs Training and Procedural Volumes Globally
    • Surging Demand for Pediatric Airway Stents Creates Opportunities for Miniaturized and Growth-Adaptive Device Designs
    • Focus on Reducing Granulation Tissue Formation and Migration Complications Drives Next-Generation Stent Development
    • Growth of Ambulatory Bronchoscopy Services Accelerates Use of Pulmonary Stents in Outpatient Settings
    • Rising Use of Pulmonary Stents in Emergency Airway Obstruction Scenarios Fuels Demand for Rapid-Deployment Systems
    • Investment in Clinical Trials and Real-World Evidence Collection Strengthens Regulatory Support and Market Confidence
    • Integration of Pulmonary Stents with Adjunctive Therapies Like Radiation and Chemotherapy Expands Multimodal Treatment Models
    • Expansion into Emerging Markets with Rising Respiratory Disease Burden Sustains Global Demand for Pulmonary Stenting Solutions
    • Focus on Sustainable Manufacturing and Biocompatible Materials Supports Eco-Efficient and Patient-Centric Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pulmonary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Self-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Balloon-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Silicon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Silicon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tracheobronchial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Tracheobronchial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Laryngeal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Laryngeal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • JAPAN
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CHINA
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • EUROPE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • FRANCE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • GERMANY
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030

IV. COMPETITION